The FDA uses a variety of toxicological assessments to evaluate the safety of substances. These assessments include acute, subchronic, and chronic toxicity studies, as well as specific tests for carcinogenicity, genotoxicity, and reproductive toxicity. The agency also considers data from human clinical trials and post-market surveillance to continuously monitor the safety of approved products.
